What is Insulin NPH?
Category: Prescription Drugs
Most popular types: Novolin N Humulin N Insulatard Show all
See also: Humulin Mix 70/30 Insulin NPH-insulin regular Mixtard 30 Penfill Novolin 70/30 PenFill Novolin Mix 70/30 Novopen Mixtard 50 HM
NPH insulin is an intermediate acting insulin used for the treatment of type 1 and type 2 diabetes mellitus to improve glycemic control. It is also used for gestational diabetes mellitus.
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Diabetes type 1 | 42 | 10 | |
| Diabetes type 2 | 40 | 8 | |
| Cystic fibrosis-related diabetes | 3 | 0 | |
| Elevated blood sugar (hyperglycemia) | 2 | 0 | |
| Diabetes insipidus | 1 | 1 | |
| Doctor recommendation | 1 | 0 |
- Major
- Moderate
- Slight
- None
- Can't tell
Side effects
Side effects as an overall problem
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 3 | |
| Mild | 3 | |
| None | 13 |
Commonly reported side effects and conditions associated with Insulin NPH
| Side effect | Patients | Percentage |
|---|---|---|
| Low blood sugar (hypoglycemia) | 3 | |
| Reactive hypoglycemia | 1 | |
| Weight gain | 1 |
Why patients stopped taking Insulin NPH
Multiple reasons could be selected
| Reason | Patients | Percentage |
|---|---|---|
| Doctor's advice | 16 | |
| Other | 10 | |
| Course of treatment ended | 7 | |
| Did not seem to work | 5 | |
| Side effects too severe | 3 | |
| Change in health plan coverage | 2 | |
| Expense | 1 |
Duration
Currently taking Insulin NPH
| Duration | Patients | Percentage |
|---|---|---|
| 2 - 5 years | 1 | |
| 5 - 10 years | 1 |
Stopped taking Insulin NPH
| Duration | Patients | Percentage |
|---|---|---|
| Less than 1 month | 1 | |
| 1 - 6 months | 2 | |
| 6 months - 1 year | 1 | |
| 1 - 2 years | 2 | |
| 2 - 5 years | 7 | |
| 5 - 10 years | 4 | |
| 10 years or more | 12 |
What people switch to and from
Patients started taking Insulin NPH after stopping:
| Treatment | Patients | Percentage |
|---|---|---|
| Gliclazide (Diamicron) | 2 | |
| Insulin Aspart (Novolog) | 1 | |
| Insulin Aspart Protamine | 1 | |
| insulin detemir (Levemir FlexPen) | 1 | |
| Insulin Glargine (Lantus) | 1 |
Patients stopped taking Insulin NPH and switched to:
| Treatment | Patients | Percentage |
|---|---|---|
| Insulin Glargine (Lantus) | 2 | |
| Amlodipine-olmesartan (Azor) | 1 | |
| Insulin Aspart (Novolog) | 1 | |
| Insulin degludec (Tresiba) | 1 | |
| Liraglutide (Victoza) | 1 |
Last updated: